Manning & Napier Advisors LLC Makes New Investment in Cuprina Holdings (Cayman) LTD $CUPR

Manning & Napier Advisors LLC purchased a new position in Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 12,630,867 shares of the company’s stock, valued at approximately $168,748,000. Cuprina Holdings (Cayman) comprises 2.2% of Manning & Napier Advisors LLC’s investment portfolio, making the stock its 15th biggest position. Manning & Napier Advisors LLC owned 1,372.92% of Cuprina Holdings (Cayman) as of its most recent filing with the Securities and Exchange Commission (SEC).

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings downgraded Cuprina Holdings (Cayman) from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, August 11th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, Cuprina Holdings (Cayman) currently has an average rating of “Sell”.

Cuprina Holdings (Cayman) Trading Down 5.7%

Shares of Cuprina Holdings (Cayman) stock opened at $2.71 on Tuesday. Cuprina Holdings has a twelve month low of $1.76 and a twelve month high of $19.60. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.35 and a current ratio of 2.35. The company’s 50 day moving average is $4.03 and its 200 day moving average is $3.25.

About Cuprina Holdings (Cayman)

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We believe we will be able to build upon and leverage such expertise to develop innovative cosmeceutical products in the future.